SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair - GZTR

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Exacctnt who wrote (210)1/21/2000 12:57:00 AM
From: Exacctnt  Read Replies (1) of 405
 
The Great Experiment Revisited. The following posts were made in May and July last year.

Message 9691873

Message 10439673

By closing above 5 today, I thought that it would be a good time to re-evaluate my position in this stock.

My decision is to continue holding the stock. With biotechs now in vogue, there is no way that I am going to part with the stock now. Momentum has arrived in the biotech sector and any company that has a good story (products) is going to benefit. Not that GZTR needs the momentum investors, but it certainly won't hurt.

With new management in place and the advancing development of the new procedures (arthoscopic and tacking), the possibility of GZTR making a profit may be within reach.

My new personal target is for GZTR to reach $10 by year's end. AT that time I will re-evaluate the position.

Of course, all bets are off if the Big Kahuna hits. <g>

Regards
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext